The drug companies and the insurance companies want us fat and unhealthy. One of the worst experiences I’ve ever had—Express Scripts is a quintessentially nefarious insurance corporation.

and Sanofi/Regeneron's Praluent (alirocumab), which have list prices of $14,000 each. Express Scripts now expects to spend no more than $750 million on the drugs in 2016, far lower than industry ...

The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

(AP) — Kentucky's attorney general has sued Express ... drugs. Kentucky has been at the epicenter of the crisis with some of ...

The FTC’s lawsuit comes just days after Express Scripts ... list price of Lilly’s insulin Humalog jumped more than 1,200% ...

Dr Steve Miller, chief medical officer at Express Scripts, says it makes no sense for cancer drugs to have the same price no matter what cancer they are treating, as the data shows some tumour ...

Blue Shield of Calif. is bypassing traditional pharmacy benefit managers to bring a Humira-referenced biosimilar, Idacio, to ...

The biggest pharmacy benefit managers are profiting by systematically underpaying independent drugstores, creating “pharmacy deserts” across the country.

Improving the Patient Financial Experience Throughout the Patient Journey While many healthcare providers believe that improving the patient financial experience is a critical step for their ...

The FTC believes that the PBMs participated in unjust competition and practices, incentivizing manufacturers to increase insulin list prices. “Express Scripts intends to vigorously defend itself to ...

The suit against Eli Lilly, CVS Pharmacy, Express Scripts ... Nordisk's diabetes and weight loss drugs Ozempic and Wegovy if the company decides to cut their list prices.